These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36597947)

  • 21. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia.
    Abulhasan YB; Ortiz Jimenez J; Teitelbaum J; Simoneau G; Angle MR
    J Neurosurg; 2021 Mar; 134(3):971-982. PubMed ID: 32217799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study.
    Muraoka S; Asai T; Fukui T; Ota S; Shimato S; Koketsu N; Nishizawa T; Araki Y; Saito R
    Neurosurg Rev; 2023 Aug; 46(1):195. PubMed ID: 37555872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine use of perfusion computed tomography for the detection of delayed cerebral ischemia in unconscious patients after aneurysmal subarachnoid hemorrhage.
    Ditz C; Hartlieb M; Neumann A; Machner B; Schacht H; Krajewski KL; Leppert J; Tronnier VM; Küchler J
    Acta Neurochir (Wien); 2021 Jan; 163(1):151-160. PubMed ID: 32910294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Balança B; Bouchier B; Ritzenthaler T
    Rev Neurol (Paris); 2022; 178(1-2):64-73. PubMed ID: 34961603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
    Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue therapy for vasospasm following aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis with machine learning.
    Martini ML; Neifert SN; Shuman WH; Chapman EK; Schüpper AJ; Oermann EK; Mocco J; Todd M; Torner JC; Molyneux A; Mayer S; Roux PL; Vergouwen MDI; Rinkel GJE; Wong GKC; Kirkpatrick P; Quinn A; Hänggi D; Etminan N; van den Bergh WM; Jaja BNR; Cusimano M; Schweizer TA; Suarez JI; Fukuda H; Yamagata S; Lo B; Leonardo de Oliveira Manoel A; Boogaarts HD; Macdonald RL;
    J Neurosurg; 2022 Jan; 136(1):134-147. PubMed ID: 34214980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Griessenauer CJ; Chua MH; Hanafy KA; Baffour YT; Chen R; LeBlanc RH; Patel AS; Salem M; Karumanchi SA; Xu D; Thadhani R; Ogilvy CS; Thomas AJ
    World Neurosurg; 2017 Dec; 108():84-89. PubMed ID: 28867315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S
    Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Amuluru K; Damodara N; El-Ghanem M; Nuoman R; Kamal N; Al-Marsoummi S; Morris NA; Dangayach NS; Mayer SA
    J Neurol Sci; 2018 Jul; 390():44-51. PubMed ID: 29801906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultra-early angiographic vasospasm associated with delayed cerebral ischemia and infarction following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Roh D; Lahiri S; Meyers E; Witsch J; Frey HP; Dangayach N; Falo C; Mayer SA; Agarwal S; Park S; Meyers PM; Connolly ES; Claassen J; Schmidt JM
    J Neurosurg; 2017 May; 126(5):1545-1551. PubMed ID: 27231975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of diagnostic strategies in suspected delayed cerebral ischemia: a decision analysis.
    Rawal S; Barnett C; John-Baptiste A; Thein HH; Krings T; Rinkel GJ
    Stroke; 2015 Jan; 46(1):77-83. PubMed ID: 25468878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stellate ganglion block combined with intra-arterial treatment: a "one-stop shop" for cerebral vasospasm after aneurysmal subarachnoid hemorrhage-a pilot study.
    Pileggi M; Mosimann PJ; Isalberti M; Piechowiak EI; Merlani P; Reinert M; Cianfoni A
    Neuroradiology; 2021 Oct; 63(10):1701-1708. PubMed ID: 33725155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.
    Thompson JC; Chalet FX; Manalastas EJ; Hawkins N; Sarri G; Talbot DA
    Neurol Ther; 2022 Jun; 11(2):597-620. PubMed ID: 35441974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
    [No Abstract]   [Full Text] [Related]  

  • 37. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
    Adami D; Berkefeld J; Platz J; Konczalla J; Pfeilschifter W; Weidauer S; Wagner M
    J Neuroradiol; 2019 Feb; 46(1):15-24. PubMed ID: 29733918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Dankbaar JW; Rijsdijk M; van der Schaaf IC; Velthuis BK; Wermer MJ; Rinkel GJ
    Neuroradiology; 2009 Dec; 51(12):813-9. PubMed ID: 19623472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.
    Durrant JC; Hinson HE
    Curr Neurol Neurosci Rep; 2015; 15(2):521. PubMed ID: 25501582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.
    Grossen AA; Ernst GL; Bauer AM
    Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.